The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Isophane Insulin Injection Market Research Report 2024
Synopsis
Isophane Insulin Injection is used in the treatment of moderate and mild diabetes patients. Severe cases must be combined with regular insulin to reduce the number of daily insulin injections and control nighttime hyperglycemia. This drug is classified under the Diabetes and other drug categories.
The global Isophane Insulin Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Isophane Insulin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Isophane Insulin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Isophane Insulin Injection include Ranbaxy Laboratories Ltd., Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd and Novo Nordisk Pharma lndia Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Isophane Insulin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isophane Insulin Injection.
Report Scope
The Isophane Insulin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Isophane Insulin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isophane Insulin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ranbaxy Laboratories Ltd.
Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
Novo Nordisk Pharma lndia Ltd.
Segment by Type
3ml/300Units
10ml/400Units
Segment by Application
People With Mild Diabetes
Patients With Severe Diabetes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Isophane Insulin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Isophane Insulin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Isophane Insulin Injection is used in the treatment of moderate and mild diabetes patients. Severe cases must be combined with regular insulin to reduce the number of daily insulin injections and control nighttime hyperglycemia. This drug is classified under the Diabetes and other drug categories.
The global Isophane Insulin Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Isophane Insulin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Isophane Insulin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Isophane Insulin Injection include Ranbaxy Laboratories Ltd., Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd and Novo Nordisk Pharma lndia Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Isophane Insulin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isophane Insulin Injection.
Report Scope
The Isophane Insulin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Isophane Insulin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isophane Insulin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ranbaxy Laboratories Ltd.
Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
Novo Nordisk Pharma lndia Ltd.
Segment by Type
3ml/300Units
10ml/400Units
Segment by Application
People With Mild Diabetes
Patients With Severe Diabetes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Isophane Insulin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Isophane Insulin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Isophane Insulin Injection Market Overview
1.1 Product Overview and Scope of Isophane Insulin Injection
1.2 Isophane Insulin Injection Segment by Type
1.2.1 Global Isophane Insulin Injection Market Value Comparison by Type (2024-2030)
1.2.2 3ml/300Units
1.2.3 10ml/400Units
1.3 Isophane Insulin Injection Segment by Application
1.3.1 Global Isophane Insulin Injection Market Value by Application: (2024-2030)
1.3.2 People With Mild Diabetes
1.3.3 Patients With Severe Diabetes
1.4 Global Isophane Insulin Injection Market Size Estimates and Forecasts
1.4.1 Global Isophane Insulin Injection Revenue 2019-2030
1.4.2 Global Isophane Insulin Injection Sales 2019-2030
1.4.3 Global Isophane Insulin Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Isophane Insulin Injection Market Competition by Manufacturers
2.1 Global Isophane Insulin Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Isophane Insulin Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Isophane Insulin Injection Average Price by Manufacturers (2019-2024)
2.4 Global Isophane Insulin Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Isophane Insulin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Isophane Insulin Injection, Product Type & Application
2.7 Isophane Insulin Injection Market Competitive Situation and Trends
2.7.1 Isophane Insulin Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Isophane Insulin Injection Players Market Share by Revenue
2.7.3 Global Isophane Insulin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Isophane Insulin Injection Retrospective Market Scenario by Region
3.1 Global Isophane Insulin Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Isophane Insulin Injection Global Isophane Insulin Injection Sales by Region: 2019-2030
3.2.1 Global Isophane Insulin Injection Sales by Region: 2019-2024
3.2.2 Global Isophane Insulin Injection Sales by Region: 2025-2030
3.3 Global Isophane Insulin Injection Global Isophane Insulin Injection Revenue by Region: 2019-2030
3.3.1 Global Isophane Insulin Injection Revenue by Region: 2019-2024
3.3.2 Global Isophane Insulin Injection Revenue by Region: 2025-2030
3.4 North America Isophane Insulin Injection Market Facts & Figures by Country
3.4.1 North America Isophane Insulin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Isophane Insulin Injection Sales by Country (2019-2030)
3.4.3 North America Isophane Insulin Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Isophane Insulin Injection Market Facts & Figures by Country
3.5.1 Europe Isophane Insulin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Isophane Insulin Injection Sales by Country (2019-2030)
3.5.3 Europe Isophane Insulin Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Isophane Insulin Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Isophane Insulin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Isophane Insulin Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Isophane Insulin Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Isophane Insulin Injection Market Facts & Figures by Country
3.7.1 Latin America Isophane Insulin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Isophane Insulin Injection Sales by Country (2019-2030)
3.7.3 Latin America Isophane Insulin Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Isophane Insulin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Isophane Insulin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Isophane Insulin Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Isophane Insulin Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Isophane Insulin Injection Sales by Type (2019-2030)
4.1.1 Global Isophane Insulin Injection Sales by Type (2019-2024)
4.1.2 Global Isophane Insulin Injection Sales by Type (2025-2030)
4.1.3 Global Isophane Insulin Injection Sales Market Share by Type (2019-2030)
4.2 Global Isophane Insulin Injection Revenue by Type (2019-2030)
4.2.1 Global Isophane Insulin Injection Revenue by Type (2019-2024)
4.2.2 Global Isophane Insulin Injection Revenue by Type (2025-2030)
4.2.3 Global Isophane Insulin Injection Revenue Market Share by Type (2019-2030)
4.3 Global Isophane Insulin Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Isophane Insulin Injection Sales by Application (2019-2030)
5.1.1 Global Isophane Insulin Injection Sales by Application (2019-2024)
5.1.2 Global Isophane Insulin Injection Sales by Application (2025-2030)
5.1.3 Global Isophane Insulin Injection Sales Market Share by Application (2019-2030)
5.2 Global Isophane Insulin Injection Revenue by Application (2019-2030)
5.2.1 Global Isophane Insulin Injection Revenue by Application (2019-2024)
5.2.2 Global Isophane Insulin Injection Revenue by Application (2025-2030)
5.2.3 Global Isophane Insulin Injection Revenue Market Share by Application (2019-2030)
5.3 Global Isophane Insulin Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ranbaxy Laboratories Ltd.
6.1.1 Ranbaxy Laboratories Ltd. Corporation Information
6.1.2 Ranbaxy Laboratories Ltd. Description and Business Overview
6.1.3 Ranbaxy Laboratories Ltd. Isophane Insulin Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ranbaxy Laboratories Ltd. Isophane Insulin Injection Product Portfolio
6.1.5 Ranbaxy Laboratories Ltd. Recent Developments/Updates
6.2 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
6.2.1 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Corporation Information
6.2.2 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Description and Business Overview
6.2.3 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Product Portfolio
6.2.5 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Recent Developments/Updates
6.3 Novo Nordisk Pharma lndia Ltd.
6.3.1 Novo Nordisk Pharma lndia Ltd. Corporation Information
6.3.2 Novo Nordisk Pharma lndia Ltd. Description and Business Overview
6.3.3 Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Product Portfolio
6.3.5 Novo Nordisk Pharma lndia Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Isophane Insulin Injection Industry Chain Analysis
7.2 Isophane Insulin Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Isophane Insulin Injection Production Mode & Process
7.4 Isophane Insulin Injection Sales and Marketing
7.4.1 Isophane Insulin Injection Sales Channels
7.4.2 Isophane Insulin Injection Distributors
7.5 Isophane Insulin Injection Customers
8 Isophane Insulin Injection Market Dynamics
8.1 Isophane Insulin Injection Industry Trends
8.2 Isophane Insulin Injection Market Drivers
8.3 Isophane Insulin Injection Market Challenges
8.4 Isophane Insulin Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Isophane Insulin Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Isophane Insulin Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Isophane Insulin Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Isophane Insulin Injection Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Isophane Insulin Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Isophane Insulin Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Isophane Insulin Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Isophane Insulin Injection Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Isophane Insulin Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Isophane Insulin Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Isophane Insulin Injection, Product Type & Application
Table 12. Global Key Manufacturers of Isophane Insulin Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Isophane Insulin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isophane Insulin Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Isophane Insulin Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Isophane Insulin Injection Sales by Region (2019-2024) & (K Doses)
Table 18. Global Isophane Insulin Injection Sales Market Share by Region (2019-2024)
Table 19. Global Isophane Insulin Injection Sales by Region (2025-2030) & (K Doses)
Table 20. Global Isophane Insulin Injection Sales Market Share by Region (2025-2030)
Table 21. Global Isophane Insulin Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Isophane Insulin Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Isophane Insulin Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Isophane Insulin Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Isophane Insulin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Isophane Insulin Injection Sales by Country (2019-2024) & (K Doses)
Table 27. North America Isophane Insulin Injection Sales by Country (2025-2030) & (K Doses)
Table 28. North America Isophane Insulin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Isophane Insulin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Isophane Insulin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Isophane Insulin Injection Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Isophane Insulin Injection Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Isophane Insulin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Isophane Insulin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Isophane Insulin Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Isophane Insulin Injection Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Isophane Insulin Injection Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Isophane Insulin Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Isophane Insulin Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Isophane Insulin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Isophane Insulin Injection Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Isophane Insulin Injection Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Isophane Insulin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Isophane Insulin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Isophane Insulin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Isophane Insulin Injection Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Isophane Insulin Injection Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Isophane Insulin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Isophane Insulin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Isophane Insulin Injection Sales (K Doses) by Type (2019-2024)
Table 51. Global Isophane Insulin Injection Sales (K Doses) by Type (2025-2030)
Table 52. Global Isophane Insulin Injection Sales Market Share by Type (2019-2024)
Table 53. Global Isophane Insulin Injection Sales Market Share by Type (2025-2030)
Table 54. Global Isophane Insulin Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Isophane Insulin Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Isophane Insulin Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Isophane Insulin Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Isophane Insulin Injection Price (US$/Dose) by Type (2019-2024)
Table 59. Global Isophane Insulin Injection Price (US$/Dose) by Type (2025-2030)
Table 60. Global Isophane Insulin Injection Sales (K Doses) by Application (2019-2024)
Table 61. Global Isophane Insulin Injection Sales (K Doses) by Application (2025-2030)
Table 62. Global Isophane Insulin Injection Sales Market Share by Application (2019-2024)
Table 63. Global Isophane Insulin Injection Sales Market Share by Application (2025-2030)
Table 64. Global Isophane Insulin Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Isophane Insulin Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Isophane Insulin Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Isophane Insulin Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Isophane Insulin Injection Price (US$/Dose) by Application (2019-2024)
Table 69. Global Isophane Insulin Injection Price (US$/Dose) by Application (2025-2030)
Table 70. Ranbaxy Laboratories Ltd. Corporation Information
Table 71. Ranbaxy Laboratories Ltd. Description and Business Overview
Table 72. Ranbaxy Laboratories Ltd. Isophane Insulin Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Ranbaxy Laboratories Ltd. Isophane Insulin Injection Product
Table 74. Ranbaxy Laboratories Ltd. Recent Developments/Updates
Table 75. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Corporation Information
Table 76. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Description and Business Overview
Table 77. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Product
Table 79. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Recent Developments/Updates
Table 80. Novo Nordisk Pharma lndia Ltd. Corporation Information
Table 81. Novo Nordisk Pharma lndia Ltd. Description and Business Overview
Table 82. Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Product
Table 84. Novo Nordisk Pharma lndia Ltd. Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Isophane Insulin Injection Distributors List
Table 88. Isophane Insulin Injection Customers List
Table 89. Isophane Insulin Injection Market Trends
Table 90. Isophane Insulin Injection Market Drivers
Table 91. Isophane Insulin Injection Market Challenges
Table 92. Isophane Insulin Injection Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Isophane Insulin Injection
Figure 2. Global Isophane Insulin Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Isophane Insulin Injection Market Share by Type in 2023 & 2030
Figure 4. 3ml/300Units Product Picture
Figure 5. 10ml/400Units Product Picture
Figure 6. Global Isophane Insulin Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Isophane Insulin Injection Market Share by Application in 2023 & 2030
Figure 8. People With Mild Diabetes
Figure 9. Patients With Severe Diabetes
Figure 10. Global Isophane Insulin Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Isophane Insulin Injection Market Size (2019-2030) & (US$ Million)
Figure 12. Global Isophane Insulin Injection Sales (2019-2030) & (K Doses)
Figure 13. Global Isophane Insulin Injection Average Price (US$/Dose) & (2019-2030)
Figure 14. Isophane Insulin Injection Report Years Considered
Figure 15. Isophane Insulin Injection Sales Share by Manufacturers in 2023
Figure 16. Global Isophane Insulin Injection Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Isophane Insulin Injection Players: Market Share by Revenue in 2023
Figure 18. Isophane Insulin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Isophane Insulin Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Isophane Insulin Injection Sales Market Share by Country (2019-2030)
Figure 21. North America Isophane Insulin Injection Revenue Market Share by Country (2019-2030)
Figure 22. United States Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Isophane Insulin Injection Sales Market Share by Country (2019-2030)
Figure 25. Europe Isophane Insulin Injection Revenue Market Share by Country (2019-2030)
Figure 26. Germany Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Isophane Insulin Injection Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Isophane Insulin Injection Revenue Market Share by Region (2019-2030)
Figure 33. China Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Isophane Insulin Injection Sales Market Share by Country (2019-2030)
Figure 43. Latin America Isophane Insulin Injection Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Isophane Insulin Injection Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Isophane Insulin Injection Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Isophane Insulin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Isophane Insulin Injection by Type (2019-2030)
Figure 53. Global Revenue Market Share of Isophane Insulin Injection by Type (2019-2030)
Figure 54. Global Isophane Insulin Injection Price (US$/Dose) by Type (2019-2030)
Figure 55. Global Sales Market Share of Isophane Insulin Injection by Application (2019-2030)
Figure 56. Global Revenue Market Share of Isophane Insulin Injection by Application (2019-2030)
Figure 57. Global Isophane Insulin Injection Price (US$/Dose) by Application (2019-2030)
Figure 58. Isophane Insulin Injection Value Chain
Figure 59. Isophane Insulin Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
